AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9250115
Drug: Wheat test
RxNorm normalized name: WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat test meal (6.3 g fiber)
Trial: 7945494
Drug: Corticosteroids (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroids (0.5 mg/kg of prednisone daily)
Trial: 27181755
Drug: Standard Diabetes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Diabetes Manual + Diabetes Treatment Guide + 30-min seminar
Trial: 27181755
Drug: Diabetes Treatment
RxNorm normalized name: Diabetes Ancillary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diabetes Treatment Guide only
Trial: 25916420
Drug: Audible music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Audible music group (MG)
Trial: 30336703
Drug: Oral naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naltrexone (50 mg daily)
Trial: 20537615
Drug: Implant naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant naltrexone (2.3 g single dose)
Trial: 20537615
Drug: Blood naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood naltrexone concentration < 0.5 ng/mL
Trial: 20537615
Drug: Blood naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood naltrexone concentration 3 ng/mL
Trial: 20537615
Drug: Implant naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant naltrexone
Trial: 20482515
Drug: Oral naltrexone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral naltrexone
Trial: 20537615
Drug: Noncompliance with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noncompliance with daily oral formula, higher baseline craving, longer history of use, being younger
Trial: 18672743
Drug: Abdominal acupuncture
RxNorm normalized name: PAD,ABDOMINAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abdominal acupuncture (n = 23), administered once daily for the first three days and once every three days for the remaining 11 days, plus placebo pill once daily
Trial: 1781820
Drug: Prednisone 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 1.5 mg/kg/d
Trial: 28129492
Drug: Topiramate (25-200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (25-200 mg/d for 12 weeks)
Trial: 26239090
Drug: High-dose UFH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose UFH (100 U/kg bolus followed by age-based continuous infusion)
Trial: 26239090
Drug: Low-dose UFH
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose UFH (50 U/kg bolus)
Trial: 26239090
Drug: UFH dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UFH dose and effect
Trial: 16311083
Drug: Combined administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined administration of octreotide and methylglucamine diatrizoate
Trial: 11757832
Drug: Ciprofloxacin +
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin + rifampicin (50 mg/L each)
Trial: 11757832
Drug: Cephradine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephradine (250 mg/L)
Trial: 9048273
Drug: Fantofarone 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fantofarone 100 mg twice daily
Trial: 9048273
Drug: Fantofarone 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fantofarone 150 mg twice daily
Trial: 9048273
Drug: Fantofarone (100-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fantofarone (100-150 mg twice daily)
Trial: 9048273
Drug: Fantofarone (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fantofarone (all doses)
Trial: 8151104
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of OA
Trial: 8151104
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g of OA
Trial: 8151104
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g of OA
Trial: 3529043
Drug: Experimental treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental treatments affecting incidence of S. aureus contamination
Trial: 24556040
Drug: Dovitinib (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dovitinib (500 mg orally, 5 days on and 2 days off)
Trial: 22270258
Drug: Sorafenib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib (400 mg orally twice daily)
Trial: 23174050
Drug: 3% SIG1273
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% SIG1273 gel
Trial: 16430546
Drug: Bupivacaine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (12 mg) + Dexmedetomidine (3 microg)
Trial: 16430546
Drug: Bupivacaine (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (12 mg) + Clonidine (30 microg)
Trial: 9254267
Drug: Magnetothermia combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnetothermia combined with chemotherapy using fluorouracil
Trial: 9254267
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with fluorouracil
Trial: 24497220
Drug: Zolpidem 10
RxNorm normalized name: zolpidem 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 10 mg/day
Trial: 26643687
Drug: Educational program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Educational program (G-I, n = 137)
Trial: 26643687
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (G-II, n = 119)
Trial: 22969230
Drug: Composite yogurt
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Composite yogurt enriched with acacia dietary fiber and Bifidobacterium lactis (B. lactis), consumed twice daily for 8 weeks
Trial: 19027263
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg bolus followed by 0.25 mg/kg per hour continuous infusion)
Trial: 19027263
Drug: Placebo (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.5 mg/kg bolus followed by 0.25 mg/kg per hour continuous infusion)
Trial: 11158748
Drug: Intrarectal artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intrarectal artesunate (10 mg/kg)
Trial: 11158748
Drug: Intrarectal artesunate
RxNorm normalized name: Artesunate
DrugBank: Artesunate (DB09274)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intrarectal artesunate (20 mg/kg)
Trial: 9266868
Drug: Albuterol every
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol every 30 min (group 1, n=34)
Trial: 9266868
Drug: Albuterol every
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol every 60 min (group 2, n=33)
Trial: 9266868
Drug: Albuterol every
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol every 120 min (group 3, n=33)
Trial: 9266868
Drug: Albuterol treatment
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol treatment for low responders (<15 percentage point increase at 15 min)
Trial: 9266868
Drug: Albuterol treatment
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol treatment for high responders (>15 percentage point increase at 15 min)
Trial: 3810772
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (high normal hemoglobin concentration, 15 g/l or more)
Trial: 3810772
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy (lower hemoglobin concentration, less than 15 g/l)
Trial: 3810772
Drug: Surgical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical therapy (extracranial‐intracranial bypass)
Trial: 27687417
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate 20 mg/kg in bolus followed by magnesium 2 mg kg(‐1) h(‐1) (group M)
Trial: 27687417
Drug: Intravenous ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketorolac 30 mg in bolus followed by saline infusion (group K)
Trial: 27687417
Drug: Intravenous saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous saline solution 20 mL in bolus followed by saline infusion during the entire procedure (group S)
Trial: 24320907
Drug: L-arginine dietary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine dietary supplement (3g)
Trial: 12727949
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg continuous estradiol with 10 mg medroxyprogesterone acetate
Trial: 12727949
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg continuous estradiol with 10 mg medroxyprogesterone acetate
Trial: 6397328
Drug: Norethisterone oenanthate
RxNorm normalized name: Oenanthic acid
DrugBank: Norethindrone enanthate (DB14678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norethisterone oenanthate (NET OEN) 200 mg injection every 60 +/‐ 5 days
Trial: 6397328
Drug: Norethisterone oenanthate
RxNorm normalized name: Oenanthic acid
DrugBank: Norethindrone enanthate (DB14678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norethisterone oenanthate (NET OEN) 200 mg injection every 90 +/‐ 5 days
Trial: 6397328
Drug: Norethisterone oenanthate
RxNorm normalized name: Oenanthic acid
DrugBank: Norethindrone enanthate (DB14678)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norethisterone oenanthate (NET OEN) 200 mg injection
Trial: 25753514
Drug: Triple combination
RxNorm normalized name: Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B
Trial: 25753514
Drug: Control side
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control side received laser treatment plus phototherapy
Trial: 19744725
Drug: Interferon (IFN)‐alfa‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN)‐alfa‐2a treatment (3 MIU subcutaneously 3 times per week for 2 years)
Trial: 19744725
Drug: Interferon (IFN)‐alfa‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN)‐alfa‐2a treatment
Trial: 11734652
Drug: Androgen ablative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen ablative therapy
Trial: 25997425
Drug: High serum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High serum NT-proBNP level on hospital admission (≥ 2,563.6 pg/ml)
Trial: 23538435
Drug: galyfilcon A/polyhexanide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: galyfilcon A/polyhexanide (combination 1)
Trial: 23538435
Drug: balafilcon A/polyquaternium‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: balafilcon A/polyquaternium‐1 and myristamidopropyl dimethylamine + TearGlyde (combination 2)
Trial: 20619623
Drug: Indacaterol 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indacaterol 600 μg
Trial: 12472345
Drug: 4% hydroquinone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4% hydroquinone cream combined with glycolic acid peels
Trial: 30958285
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave therapy (3 sessions, once every 4-5 days)
Trial: 30958285
Drug: Combined extracorporeal
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined extracorporeal shock wave therapy (3 sessions, once every 4-5 days) and local use of silicone gel Strataderm
Trial: 15545060
Drug: Inhaled corticosteroid
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroid (800 microg of budesonide) for 12 weeks
Trial: 11244659
Drug: Thermal balloon
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thermal balloon ablation therapy
Trial: 12297711
Drug: Gestagen therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestagen therapy
Trial: 9850017
Drug: Short chemotherapy
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short chemotherapy (6 months) with vincristine and dactinomycin (pulse-intensive)
Trial: 9850017
Drug: Long chemotherapy
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long chemotherapy (9 additional months) with vincristine and dactinomycin (pulse-intensive)
Trial: 9850017
Drug: Short PI
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short PI treatment regimens
Trial: 1078711
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment (control)
Trial: 30544793
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group (received free vision care and eyeglasses)
Trial: 30544793
Drug: Treatment group
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment group membership
Trial: 26758402
Drug: Captopril 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 1% ointment
Trial: 19866403
Drug: 3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg/kg of oral sildenafil every 6 hours
Trial: 18416077
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment for one month at main points (Zhongwan (CV 12), Zusanli (ST 36), Taichong (LR 3), Shenmen (HT 7))
Trial: 18416077
Drug: Domperidone orally
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone orally administered for one month
Trial: 16938781
Drug: Second identical
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Second identical cochlear implant in the contralateral ear immediately
Trial: 1452964
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg dietary calcium per day
Trial: 1452964
Drug: 1,500 mg
RxNorm normalized name: garlic 1,500 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,500 mg dietary calcium per day
Trial: 26591358
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine (CM) group - WYHZTLR decoction (one dose per day)
Trial: 26591358
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (WM) group - penicillamine tablet (0.125 g, bid) and Prednisone Acetate Tablet (PAT 20 mg, qd)
Trial: 26591358
Drug: Integrative medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrative medicine (IM) group - penicillamine, PAT, and WYHZTLR decoction (same dosages as above)
Trial: 19232061
Drug: Background therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Background therapy and/or early rescue
Trial: 10566728
Drug: SP-303 (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SP-303 (500 mg p.o. every 6 h for 96 h)
Trial: 8729191
Drug: Tamoxifen (endocrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (endocrine therapy)
Trial: 1867617
Drug: 0.25% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% plain bupivacaine (local injection)
Trial: 1867617
Drug: 0.25% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% plain bupivacaine (topical application)
Trial: 1867617
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl (control for local injection)
Trial: 1867617
Drug: 0.9% NaCl
RxNorm normalized name: Trace Metals Additive in 0.9% NaCl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% NaCl (control for topical application)
Trial: 6409958
Drug: Oral zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zinc load
Trial: 19758763
Drug: Cognitive intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive intervention (CI) prior to injection with CRH
Trial: 14504028
Drug: BUP 8
RxNorm normalized name: Buprenorphine
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: BUP 8 mg s.l. tablet
Trial: 14504028
Drug: METH 60
RxNorm normalized name: CALCIUM CARB 1GM/SIMETH 60MG CHEW TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: METH 60 mg/day
Trial: 380909
Drug: Amineptine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amineptine (200 mg per day)
Trial: 3027832
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of itraconazole daily
Trial: 3027832
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg of itraconazole daily
Trial: 3027832
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg or 100 mg of itraconazole daily
Trial: 29484877
Drug: Neurologic music
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurologic music therapy for 16 weeks in addition to usual physiotherapy
Trial: 29484877
Drug: Usual therapeutic
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual therapeutic input without neurologic music therapy
Trial: 24132773
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg soft-gel capsule of acetylsalicylic acid (ASA)
Trial: 24132773
Drug: marketed powder
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: marketed powder for oral solution
Trial: 21626815
Drug: Akatinol memantine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Akatinol memantine (5-10 mg/day, increased to 20 mg/day over 90 days)
Trial: 17592907
Drug: Adjunctive aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adjunctive aripiprazole (2-15 mg/day with fluoxetine or paroxetine; 2-20 mg/day with all others)
Trial: 9772598
Drug: Morphine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (2 mg)
Trial: 19459553
Drug: Bupivacaine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (100 mg)
Trial: 12802484
Drug: Saline (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (20 ml)
Trial: 11836043
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg E2/0.5 mg NETA (low-dose HRT)
Trial: 11836043
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg E2/1 mg NETA (high-dose HRT)
Trial: 2023370
Drug: Beta-blockers in
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers in aqueous solution
Trial: 31804186
Drug: Web-based self-titration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based self-titration program
Trial: 26446331
Drug: 0.5 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg of 20% intravenous mannitol infusion over 10 minutes before induction of anesthesia (group M)
Trial: 26446331
Drug: 0.5 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg of 20% intravenous mannitol infusion (group M)
Trial: 20230185
Drug: Steroid-free regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free regimen (Tacrolimus, Mycophenolate mofetil, Basiliximab induction, steroids for 3 days)
Trial: 20230185
Drug: Steroid maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid maintenance regimen (Tacrolimus, Mycophenolate mofetil, Basiliximab induction, steroid maintenance)
Trial: 18056435
Drug: High cysteinylglycine
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High cysteinylglycine levels in the high alcohol intake group (>or=9 g/day)
Trial: 10025442
Drug: 85.8 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 85.8 g amino acid mixture lacking tryptophan
Trial: 31308304
Drug: Once-daily insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily insulin degludec/insulin aspart (IDegAsp), n = 26
Trial: 31308304
Drug: Once-daily basal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily basal insulin (insulin degludec and insulin glargine 300 units/mL), n = 26
Trial: 25679398
Drug: Darbepoietin‐α treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darbepoietin‐α treatment
Trial: 23594239
Drug: Daily dose
RxNorm normalized name: LENVIMA 8mg Daily Dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily dose of 325 mg of aspirin (ASA)
Trial: 21394642
Drug: Bradykinin (B(2)
RxNorm normalized name: Bradykinin
DrugBank: Bradykinin (DB12126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bradykinin (B(2) agonist)
Trial: 21394642
Drug: Lys‐des‐Arg(9)‐bradykinin (B(1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lys‐des‐Arg(9)‐bradykinin (B(1) agonist)